Phase 2 AML, Adult Clinical Trials
7 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–7 of 7 trials
Recruiting
Phase 1Phase 2
BSB-1001 in Patients Undergoing HLA-Matched Allogenic Hematopoietic Stem Cell Transplant for AML, ALL or MDS
MDSAML, Adult RecurrentALL, Recurrent, Adult
BlueSphere Bio, Inc38 enrolled6 locationsNCT06704152
Recruiting
Phase 2
Pharmacoscopy-guided Clinical Standard-of-care in r/r AML
AML, Adult
ETH Zurich88 enrolled2 locationsNCT06138990
Recruiting
Phase 2
Study Investigating the Efficacy and Safety of the Addition of Oral-azacitidine to Salvage Treatment by Gilteritinib in Subjects ≥18 Years of Age With Relapsed/Refractory FLT3-mutated Acute Myeloid Leukemia
AML, AdultRefractory AMLRelapsed Adult AML+2 more
French Innovative Leukemia Organisation33 enrolled20 locationsNCT06022003
Recruiting
Phase 1Phase 2
Sequential CAR-T Cells Targeting CD33/CD123 in Patients With Acute Myelocytic Leukemia AML
Acute Myeloid LeukemiaAMLAML, Adult+1 more
Essen Biotech85 enrolled1 locationNCT06420063
Recruiting
Phase 2
A Trial to Assess Cobicistat Boosted Venetoclax in Combination With Azacitidine in Adult Patients With Newly Diagnosed AML
AML, Adult
Stichting Hemato-Oncologie voor Volwassenen Nederland142 enrolled18 locationsNCT06014489
Recruiting
Phase 2
A Study of Selinexor in Combination With Azacitidine and Venetoclax (SAV Regimen) in Treatment Naïve Participants With Acute Myeloid Leukemia
AML, Adult
Shanghai Tong Ren Hospital58 enrolled19 locationsNCT05736965
Recruiting
Phase 2
Precision Therapy Versus Standard Therapy in AML and MDS in Elderly
MDSAML, Adult
University Hospital, Akershus36 enrolled1 locationNCT05025098